Cafepharma Today

May 28 2025 - GLP-1 prescriptions for weight loss soar, despite obstacles
GLP-1 prescriptions for weight loss soar, despite obstacles
FDA approves use of Sanofi's meningococcal vaccine in infants
GSK's $66M bet on Spero's rejected UTI antibiotic pays off with a phase 3 win
AbbVie's Allergan Aesthetics unit plots 202 layoffs after recent sales slide
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Cel-Sci Cancer Drug Claims Crumble (Part 2)
TheStreet.com
Thursday, February 11, 2010 - 8:41am
tags:
Cel-Sci, Multikine, cancer
Cel-Sci Cancer Drug Claims Crumble (Part 1)
TheStreet.com
Thursday, February 11, 2010 - 8:39am
tags:
Cel-Sci, cancer, Multikine
Boston Scientific To Restructure, Cut 1,000 Jobs
Reuters
Thursday, February 11, 2010 - 8:38am
tags:
layoffs, Boston Scientific, restructuring
Roche’s Diabetes Drug Meets Goals in Five Studies
Bloomberg
Thursday, February 11, 2010 - 8:36am
tags:
Roche, diabetes, clinical trials, Lantus, Byetta, Januvia, taspoglutide, Eli Lilly, Merck, Amylin, Sanofi
Fast-growing generics ripe for consolidation
Fierce Pharma
Wednesday, February 10, 2010 - 6:46pm
tags:
generics
Investors Give ISIS The Cold Shoulder
Forbes
Wednesday, February 10, 2010 - 6:44pm
tags:
Isis Pharmaceuticals, Genzyme, mipomersen
Boston Scientific Narrows Loss on Higher Sales
Bloomberg
Wednesday, February 10, 2010 - 6:43pm
tags:
Boston Scientific, earnings
Vioxx Lawsuits: What’s Been Settled, What’s Still Going?
WSJ Online
Wednesday, February 10, 2010 - 6:35pm
tags:
Vioxx, Merck, settlements, lawsuits
The art of the deal, Sanofi-style
Fierce Pharma
Wednesday, February 10, 2010 - 11:08am
tags:
Sanofi, M&A
Rexahn: The Undiscovered Biotech
Seeking Alpha
Wednesday, February 10, 2010 - 10:42am
tags:
Rexahn, Teva Pharmaceuticals, Pfizer, Eli Lilly, GSK
Icahn's Smiling -- Should We Be?
Motley Fool
Wednesday, February 10, 2010 - 10:26am
tags:
Carl Icahn, Biogen Idec
Medicare Pay Cuts to Doctors: The Latest Patch
WSJ Online
Wednesday, February 10, 2010 - 10:25am
tags:
Medicare, reimbursement
Boehringer to Buy Japanese Consumer-Drug Producer SSP
Bloomberg
Wednesday, February 10, 2010 - 10:22am
tags:
Boehringer Ingelheim, Japan, M&A, SSP
Drug stocks dip; Isis tumbles on drug data
Marketwatch
Wednesday, February 10, 2010 - 10:21am
tags:
drug stocks, Isis Pharmaceuticals
Sanofi-Aventis chops into R&D budget, drops cancer drug
Fierce Biotech
Wednesday, February 10, 2010 - 9:37am
tags:
Sanofi, R&D
Alexza, Biovail to commercialize psychiatric drug
Marketwatch
Wednesday, February 10, 2010 - 9:35am
tags:
Biovail, Alexza, bipolar disorder, schizophrenia
Genzyme, Isis report positive study on heart drug
Marketwatch
Wednesday, February 10, 2010 - 9:29am
tags:
Isis Pharmaceuticals, Genzyme, mipomersen, cholesterol
Amgen Gets More Good Data with Bone Drug Prolia, but Other Risks Await
BNET Pharma
Wednesday, February 10, 2010 - 9:01am
tags:
Amgen, Prolia, Novartis, Zometa, denosumab
Elan expects rare operating profit in 2010
Reuters
Wednesday, February 10, 2010 - 9:00am
tags:
Elan, earnings, guidance
Merck to Change Safety Procedures, Pay Fees to End Vioxx Suits
Bloomberg
Wednesday, February 10, 2010 - 7:47am
tags:
settlements, Merck, Vioxx

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline
Lose Your Crystalline Form and Go Amorphous
In the Pipeline
Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.